A peptide — a short chain of amino acids, the building blocks of proteins — called BPC 157 may prevent…
Articles by Margarida Maia, PhD
Certain chemokines — signaling molecules that attract white blood cells to sites of infection — may be blood markers of…
Non-alcoholic fatty liver disease (NAFLD) — an umbrella term for conditions caused by a buildup of fat in the liver…
Pregnant women with high pressure in the pulmonary artery of the heart, but who are not considered at risk of…
Levels of a protein found in certain blood cells indicate the severity and prognosis of pulmonary arterial hypertension (PAH),…
Claritas Pharmaceuticals has signed a letter of intent with the Salzman Group to acquire exclusive global rights to develop…
United Therapeutics has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval of Tyvaso DPI, a…
More than three-quarters (76%) of adults with pulmonary arterial hypertension (PAH) being treated with Uptravi (selexipag) either saw…
Patients whose pulmonary hypertension is associated with chronic obstructive pulmonary disease (PH-COPD) have a worse clinical status and a poorer…
Treatment with Acceleron Pharma’s sotatercept appears to be effective and generally well tolerated in people with pulmonary…
VeriSIM Life has opened PulmoSIM Therapeutics, its pharmaceutical subsidiary focused on developing treatments for pulmonary arterial hypertension (PAH) and…
Pulmonary hypertension (PH) occurs in 60% of children with the heart defect known as patent ductus arteriosus, with girls…